Jump to Header Jump to Main Content Jump to Footer

Ph I Study of IGM-8444 as a Single Agent & in Combo in Subjects w/ Relapsed &/or Refr Solid Cancers

Warren A Chow


A Study On:

  • Other

Status:

  • Open

Eligibility

Adult

Interested in joining this trial?

Official Title

An Open-Label, Multicenter, Phase I Study of IGM-8444 as a Single Agent and in Combination in Subjects with Relapsed and/or Refractory Solid Cancers


Eligibility

You can join if...

You can participate in this study if you are at least 18 years of age or older; have been clinically diagnosed with of locally advanced or metastatic cancer. You cannot participate in this study if you are pregnant or breast feeding; if you are using medication well known to cause liver toxicity.

Get in touch with our study team